Headquarters
1660 Soldiers Field Road,
STE 7, #1063
Brighton MA 02135
R&D Laboratory
M2D2 Umass Lowell, 110 Canal St, 4th Floor, Lowell MA 01852
Read our latest press releases to learn how Gel4Med is driving innovation and impact across the life sciences.
February 9, 2026
Gel4Med, Inc., a leader in advanced biomaterials engineering and a pioneer in next-generation peptide-based technologies, today announced expanded acute-care and surgical-suite market access for G4Derm™ Plus Biomimetic Matrix (BMM™) through a distribution collaboration involving Summit Products Group and MiMEDX Group, Inc. (Nasdaq: MDXG).
September 04, 2025
Gel4Med, Inc., a leading company in advanced biomaterials for regenerative medicine, is proud to announce that its groundbreaking wound healing product G4Derm™ Plus Biomimetic Matrix (BMM), has been featured in the August 2025 issue of the Podiatry Management Magazine.
August 28, 2025
Gel4Med, a commercial-stage biomaterials company, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique Healthcare Common Procedure Coding System (HCPCS) Level II code, A2037, for G4Derm™ Plus.
July 14, 2025
Gel4Med, Inc., a leader in advanced bio-design pioneering the next-generation of biomaterials, today announced it has been awarded highly competitive funding from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to support the continued development of its advanced wound care and surgical reconstruction portfolio.
July 2, 2025
Gel4Med, a leader in advanced biomaterials engineering, proudly announces a partnership with Spartan Medical, a trusted leader in medical solutions to Veterans Affairs (VA) Medical Centers and Department of Defense (DoD) Military Treatment Facilities.
June 3, 2025
Gel4Med Awarded Mass Ventures START Grant to Accelerate Innovation in Tissue Engineering and Advanced Biomaterials Development.
May 27, 2025
Massachusetts General Hospital / Harvard Medical School publishes real-world evidence case series on G4Derm™ Plus biomimetic matrix (BMM™), highlighting rapid healing of diabetic foot ulcers (DFUs) refractory to advanced wound treatments.
July 9, 2024
Gel4Med, an innovative biomaterials company, is proud to announce that Podiatry Today has recognized their first product, G4Derm™ Plus, as one of the Top 10 Innovations in Podiatry.
May 01, 2024
Gel4Med and University of Miami funded to collaborate and innovate around novel treatments for Spinal Cord Injury.
October 05, 2023
The highly competitive National Institutes of Health Commercial Readiness Pilot (CRP) program awards Gel4Med with significant funding for the commercial launch of their lead asset.
October 23, 2023
Wound healing is a long-term, multistage biological process that includes hemostasis...
For press and media inquires, please email bd@gelformed.com
1660 Soldiers Field Road,
STE 7, #1063
Brighton MA 02135
M2D2 Umass Lowell, 110 Canal St, 4th Floor, Lowell MA 01852
